Growth momentum Remedy Analytics is a fast-growing pharma analytics provider with revenue in the mid six-figure to low seven-figure range and a notable placement on the 2020 Inc. 5000 list, suggesting a proven trajectory that may attract partnerships or minority investments from larger healthcare players.

Strategic fit Acquired by Brown & Brown, Remedy’s data analytics and clinical intelligence platform (PharmaLogic) align with insurers and plan sponsors seeking spend optimization and population health management, presenting opportunities for collaboration with captive agencies, reinsurers, and employers seeking improved pharmacy benefits.

Tech stack Key technologies include HIPAA-compliant data practices, Oracle SQL, Django and PHP, and data/claims analytics for PBM-driven insights, signaling suitability for integration with large benefit platforms, PBMs, or health IT ecosystems seeking compatible analytics modules.

Market position Benchmarked against large industry players with extensive scale, Remedy’s niche as a focused analytics and consulting vendor offers a route for enterprise customers to pilot targeted pharma benefits optimization before scaling with bigger providers.

Engagement opportunities With full-service Rx consulting from RFP to implementation and a clinical/data science team, there are cross-sell opportunities into plan sponsors, brokers, and TPAs, as well as potential for expansion through Brown & Brown’s distribution network and partner channels.